Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 4
1952 2
1953 3
1954 2
1955 3
1956 5
1957 10
1958 4
1959 3
1960 5
1961 6
1962 4
1963 4
1964 1
1965 1
1966 2
1967 7
1968 10
1969 17
1970 15
1971 7
1972 9
1973 20
1974 6
1975 19
1976 24
1977 25
1978 18
1979 21
1980 18
1981 21
1982 18
1983 9
1984 13
1985 7
1986 10
1987 6
1988 12
1989 9
1990 8
1991 9
1992 1
1993 7
1994 6
1995 9
1996 7
1997 8
1998 9
1999 7
2000 7
2001 10
2002 12
2003 7
2004 5
2005 11
2006 11
2007 6
2008 2
2009 9
2010 6
2011 15
2012 13
2013 15
2014 12
2015 20
2016 20
2017 14
2018 27
2019 21
2020 19
2021 31
2022 27
2023 31
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

788 results

Results by year

Filters applied: . Clear all
Page 1
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis.
Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonça LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, Mailhot-Léonard F, Ahmed E, Belle J, Besla R, Mazer B, King IL, Nijnik A, Robbins CS, Barreiro LB, Divangahi M. Kaufmann E, et al. Among authors: grenier jc. Cell. 2018 Jan 11;172(1-2):176-190.e19. doi: 10.1016/j.cell.2017.12.031. Cell. 2018. PMID: 29328912 Free article.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Bidard FC, Hardy-Bessard AC, Dalenc F, Bachelot T, Pierga JY, de la Motte Rouge T, Sabatier R, Dubot C, Frenel JS, Ferrero JM, Ladoire S, Levy C, Mouret-Reynier MA, Lortholary A, Grenier J, Chakiba C, Stefani L, Plaza JE, Clatot F, Teixeira L, D'Hondt V, Vegas H, Derbel O, Garnier-Tixidre C, Canon JL, Pistilli B, André F, Arnould L, Pradines A, Bièche I, Callens C, Lemonnier J, Berger F, Delaloge S; PADA-1 investigators. Bidard FC, et al. Among authors: grenier j. Lancet Oncol. 2022 Nov;23(11):1367-1377. doi: 10.1016/S1470-2045(22)00555-1. Epub 2022 Sep 29. Lancet Oncol. 2022. PMID: 36183733 Clinical Trial.
Evolution of immune genes is associated with the Black Death.
Klunk J, Vilgalys TP, Demeure CE, Cheng X, Shiratori M, Madej J, Beau R, Elli D, Patino MI, Redfern R, DeWitte SN, Gamble JA, Boldsen JL, Carmichael A, Varlik N, Eaton K, Grenier JC, Golding GB, Devault A, Rouillard JM, Yotova V, Sindeaux R, Ye CJ, Bikaran M, Dumaine A, Brinkworth JF, Missiakas D, Rouleau GA, Steinrücken M, Pizarro-Cerdá J, Poinar HN, Barreiro LB. Klunk J, et al. Among authors: grenier jc. Nature. 2022 Nov;611(7935):312-319. doi: 10.1038/s41586-022-05349-x. Epub 2022 Oct 19. Nature. 2022. PMID: 36261521 Free PMC article.
IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease.
Abadie V, Kim SM, Lejeune T, Palanski BA, Ernest JD, Tastet O, Voisine J, Discepolo V, Marietta EV, Hawash MBF, Ciszewski C, Bouziat R, Panigrahi K, Horwath I, Zurenski MA, Lawrence I, Dumaine A, Yotova V, Grenier JC, Murray JA, Khosla C, Barreiro LB, Jabri B. Abadie V, et al. Among authors: grenier jc. Nature. 2020 Feb;578(7796):600-604. doi: 10.1038/s41586-020-2003-8. Epub 2020 Feb 12. Nature. 2020. PMID: 32051586 Free PMC article.
Withdrawal notice to « Patients sous Palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ? » [Bull Cancer 108 (2021) 544–552 https://doi.org/10.1016/j.bulcan.2021.01.007].
Vazquez L, Arnaud A, Grenier J, Debourdeau P. Vazquez L, et al. Among authors: grenier j. Bull Cancer. 2024 Jan;111(1):124. doi: 10.1016/j.bulcan.2023.11.009. Bull Cancer. 2024. PMID: 38245330 French. No abstract available.
The gene regulatory basis of bystander activation in CD8+ T cells.
Watson NB, Patel RK, Kean C, Veazey J, Oyesola OO, Laniewski N, Grenier JK, Wang J, Tabilas C, Yee Mon KJ, McNairn AJ, Peng SA, Wesnak SP, Nzingha K, Davenport MP, Tait Wojno ED, Scheible KM, Smith NL, Grimson A, Rudd BD. Watson NB, et al. Among authors: grenier jk. Sci Immunol. 2024 Feb 23;9(92):eadf8776. doi: 10.1126/sciimmunol.adf8776. Epub 2024 Feb 23. Sci Immunol. 2024. PMID: 38394230
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.
Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE. Moffat J, et al. Among authors: grenier jk. Cell. 2006 Mar 24;124(6):1283-98. doi: 10.1016/j.cell.2006.01.040. Cell. 2006. PMID: 16564017 Free article.
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Huober J, Weder P, Ribi K, Thürlimann B, Thery JC, Li Q, Vanlemmens L, Guiu S, Brain E, Grenier J, Dalenc F, Levy C, Savoye AM, Müller A, Membrez-Antonioli V, Gérard MA, Lemonnier J, Hawle H, Dietrich D, Boven E, Bonnefoi H; Swiss Group for Clinical Cancer Research, Unicancer Breast Group, and Dutch Breast Cancer Research Group. Huober J, et al. Among authors: grenier j. JAMA Oncol. 2023 Oct 1;9(10):1381-1389. doi: 10.1001/jamaoncol.2023.2909. JAMA Oncol. 2023. PMID: 37561451
788 results